These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35413924)

  • 1. Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters.
    Maliko N; Stam MR; Boersma LJ; Vrancken Peeters MTFD; Wouters MWJM; KleinJan E; Mulder M; Essers M; Hurkmans CW; Bijker N
    Radiat Oncol; 2022 Apr; 17(1):73. PubMed ID: 35413924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
    Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
    Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of patient and treatment characteristics on heart and lung dose in adjuvant radiotherapy for left-sided breast cancer.
    Finazzi T; Nguyen VT; Zimmermann F; Papachristofilou A
    Radiat Oncol; 2019 Aug; 14(1):153. PubMed ID: 31462267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep inspiration breath-hold intensity modulated radiation therapy in a large clinical series of 239 left-sided breast cancer patients: a dosimetric analysis of organs at risk doses and clinical feasibility from a single center experience.
    Testolin A; Ciccarelli S; Vidano G; Avitabile R; Dusi F; Alongi F
    Br J Radiol; 2019 Sep; 92(1101):20190150. PubMed ID: 31265316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects.
    Thorsen LB; Thomsen MS; Berg M; Jensen I; Josipovic M; Overgaard M; Overgaard J; Skogholt P; Offersen BV;
    Acta Oncol; 2014 Aug; 53(8):1027-34. PubMed ID: 24957557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
    Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
    Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?
    Mayinger M; Borm KJ; Dreher C; Dapper H; Duma MN; Oechsner M; Kampfer S; Combs SE; Habermehl D
    Radiat Oncol; 2019 Aug; 14(1):135. PubMed ID: 31370876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
    Karpf D; Sakka M; Metzger M; Grabenbauer GG
    Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.
    van den Ende RPJ; Peters FP; Harderwijk E; Rütten H; Bouwmans L; Berbee M; Canters RAM; Stoian G; Compagner K; Rozema T; de Smet M; Intven MPW; Tijssen RHN; Theuws J; van Haaren P; van Triest B; Eekhout D; Marijnen CAM; van der Heide UA; Kerkhof EM
    Radiat Oncol; 2020 Feb; 15(1):41. PubMed ID: 32070386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study].
    Bourgier C; Pichenot C; Verstraet R; Heymann S; Biron B; Balleyguier C; Delaloge S; Mathieu MC; Uzan C; Garbay JR; Bourhis J; Taghian A; Marsiglia H
    Cancer Radiother; 2010 Dec; 14(8):718-26. PubMed ID: 20674444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we consider thyroid gland as an organ at risk in carcinoma breast patients receiving adjuvant radiation by conformal technique? A single institute dosimetric study.
    Madisetty A; Suryadevara A; Chinta SK; Vuppu S; R Marella VR
    Indian J Cancer; 2020; 57(4):393-397. PubMed ID: 33078745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we predict plan quality for external beam partial breast irradiation: results of a multicenter feasibility study (Trans Tasman Radiation Oncology Group Study 06.02).
    Kron T; Willis D; Link E; Lehman M; Campbell G; O'Brien P; Chua B
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):817-24. PubMed ID: 24064318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry and outcomes in patients receiving radiotherapy for synchronous bilateral breast cancers.
    McKenzie E; Razvi Y; Bosnic S; Wronski M; Zhang L; Karam I; Donovan E; Milton L; Behroozian T; Drost L; Yee C; Wong G; Lam E; Chow E
    J Med Imaging Radiat Sci; 2021 Dec; 52(4):527-543. PubMed ID: 34580051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
    Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
    J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy.
    Tang S; Otton J; Holloway L; Delaney GP; Liney G; George A; Jameson M; Tran D; Batumalai V; Thomas L; Koh ES
    Radiother Oncol; 2019 Mar; 132():257-265. PubMed ID: 30446318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation.
    Cho Y; Cho YJ; Chang WS; Kim JW; Choi WH; Lee IJ
    Radiat Oncol; 2019 Apr; 14(1):56. PubMed ID: 30935400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
    Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices.
    Pierce LJ; Feng M; Griffith KA; Jagsi R; Boike T; Dryden D; Gustafson GS; Benedetti L; Matuszak MM; Nurushev TS; Haywood J; Radawski JD; Speers C; Walker EM; Hayman JA; Moran JM;
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1154-1161. PubMed ID: 28927756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.